Astrazeneca Pharma India Ltd

About [ edit ]

Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.

  • Market Cap 9,537 Cr.
  • Current Price 3,816
  • High / Low 4,970 / 2,595
  • Stock P/E 126
  • Book Value 162
  • Dividend Yield 0.05 %
  • ROCE 33.9 %
  • ROE 21.7 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 40.40% CAGR over last 5 years

Cons

  • Stock is trading at 23.55 times its book value
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
151 161 161 215 190 205 208 224 195 194 209 200
135 152 147 174 184 169 175 187 180 165 174 170
Operating Profit 15 9 15 41 6 36 34 37 15 29 36 31
OPM % 10% 6% 9% 19% 3% 17% 16% 16% 8% 15% 17% 15%
Other Income 2 3 3 4 6 3 3 3 3 3 5 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 4 4 4 4 5 5 5 5 5 5 5
Profit before tax 14 9 14 41 8 34 32 35 13 26 36 28
Tax % 77% 30% 37% 28% -16% 36% 55% 24% 28% 29% 26% 26%
Net Profit 3 6 9 29 10 22 14 27 10 19 26 21
EPS in Rs 1.29 2.56 3.65 11.64 3.93 8.61 5.77 10.68 3.83 7.45 10.54 8.42

Profit & Loss

Figures in Rs. Crores

Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
353 397 594 531 390 474 517 564 544 571 728 832 798
241 307 490 501 459 487 528 547 507 525 657 711 688
Operating Profit 113 90 104 30 -68 -13 -11 16 37 46 71 121 110
OPM % 32% 23% 17% 6% -18% -3% -2% 3% 7% 8% 10% 15% 14%
Other Income 14 5 6 6 10 23 6 7 14 12 16 13 14
Interest 5 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 7 6 9 7 12 10 15 17 16 15 15 19 19
Profit before tax 114 88 101 29 -70 0 -21 6 36 44 73 114 104
Tax % 35% 35% 36% 32% -27% 0% 9% 44% 41% 25% 37%
Net Profit 74 58 64 20 -90 -1 -21 5 20 26 54 72 76
EPS in Rs 29.54 23.05 25.65 7.90 -35.81 -0.20 -8.34 2.10 8.02 10.36 21.78 28.88 30.24
Dividend Payout % 51% 43% 39% 44% 0% 0% 0% 0% 0% 0% 0% 3%
Compounded Sales Growth
10 Years:8%
5 Years:10%
3 Years:15%
TTM:-4%
Compounded Profit Growth
10 Years:2%
5 Years:40%
3 Years:66%
TTM:4%
Stock Price CAGR
10 Years:11%
5 Years:27%
3 Years:50%
1 Year:17%
Return on Equity
10 Years:6%
5 Years:15%
3 Years:18%
Last Year:22%

Balance Sheet

Figures in Rs. Crores

Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
5 5 5 5 5 5 5 5 5 5 5 5 5
Reserves 111 140 175 184 95 167 146 151 218 242 296 359 400
Borrowings 62 0 0 0 0 0 0 0 0 0 0 12 12
110 89 129 156 206 244 261 247 193 214 261 330 303
Total Liabilities 288 234 309 345 306 416 412 403 415 461 562 706 720
30 30 27 32 25 94 101 97 87 75 75 72 78
CWIP 0 0 24 58 74 9 12 6 5 4 7 24 12
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
258 204 257 255 208 312 298 299 324 382 480 611 630
Total Assets 288 234 309 345 306 416 412 403 415 461 562 706 720

Cash Flows

Figures in Rs. Crores

Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
82 33 64 39 -6 -1 -46 57 38 9 55 87
5 2 -28 -34 -16 -15 -19 -4 0 -9 4 -171
-54 -111 -29 -29 -10 86 0 -1 0 0 0 -6
Net Cash Flow 33 -76 8 -24 -32 71 -64 53 38 -1 59 -90

Ratios

Figures in Rs. Crores

Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 71% 55% 62% 15% -53% -12% -13% 4% 15% 19% 27% 34%
Debtor Days 52 63 27 22 26 41 30 54 29 35 40 37
Inventory Turnover 3.52 3.55 3.95 2.75 2.00 1.93 2.29 2.54 2.70 2.21 2.07 2.21

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
0.45 0.49 0.59 1.69 2.17 2.74 2.05 1.22 1.19 1.98 2.36 2.43
5.80 5.50 5.37 4.63 4.36 3.61 3.71 3.66 3.39 2.33 1.46 0.93
18.75 19.01 19.04 18.68 18.47 18.65 19.24 20.12 20.42 20.69 21.18 21.64

Documents